tirzepatide brain health A novel therapeutic prospect: a dual-acting for Alzheimer's disease Tirzepatide for Medical Weight Loss
Description
Explore the retatrutide dosing schedule from Phase 2 and 3 clinical trials: escalation protocol, weekly doses, and trial data
Semaglutide is a popular weight loss drug that also treats diabetes, but new research shows a troubling trend
Starting at 241 lb, she lost 90 lb (over 30% of her body weight) over 65 weeks without side effects
In the largest pharmacogenomics GWAS of GLP-1 medications to date (15,237 participants, replicated in the All of Us cohort), researchers identified a missense variant in GLP1R the gene encoding the very receptor that semaglutide and tirzepatide bind that significantly predicts how much weight a person loses on treatment
